Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Silence Therapeutics

SLNNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$5.12

0.091.79%

At close: -

$5.12

0.000.00%

After Hours: Jan 17, 7:57 PM EDT

Silence Therapeutics (SLN) Forecast

News

Earnings Silence Therapeutics (SLN) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Silence Therapeutics (NASDAQ:SLN) Stock

Silence Therapeutics Stock (NASDAQ: SLN)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, December 18, 2024

Top 3 Health Care Stocks That May Explode In Q4
Avi Kapoor

Tuesday, December 10, 2024

The Analyst Landscape: 6 Takes On Silence Therapeutics
Benzinga Insights
Chardan Capital Maintains Buy on Silence Ther...
Benzinga Newsdesk

Wednesday, November 20, 2024

HC Wainwright & Co. Reiterates Buy on Silence...
Benzinga Newsdesk

Tuesday, November 19, 2024

Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst
Vandana Singh
Top 3 Health Care Stocks You'll Regret Missing In Q4
Avi Kapoor

Monday, November 18, 2024

Silence Therapeutics Presents Late-Breaking P...
Benzinga Newsdesk

Friday, November 15, 2024

Analyst Scoreboard: 4 Ratings For Silence Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Silence...
Benzinga Newsdesk

Thursday, November 14, 2024

Chardan Capital Maintains Buy on Silence Ther...
Benzinga Newsdesk
CORRECTION: Silence Therapeutics Q3 EPS $(0.7...
Benzinga Newsdesk

Tuesday, October 08, 2024

Morgan Stanley Reiterates Overweight on Silen...
Benzinga Newsdesk

Friday, August 30, 2024

HC Wainwright & Co. Reiterates Buy on Silence...
Benzinga Newsdesk

Friday, August 16, 2024

Analyst Expectations For Silence Therapeutics's Future
Benzinga Insights
Chardan Capital Maintains Buy on Silence Ther...
Benzinga Newsdesk

Thursday, August 15, 2024

Silence Therapeutics Q2 EPS (11.10) Pence Dow...
Benzinga Newsdesk

Friday, June 28, 2024

Morgan Stanley Maintains Overweight on Silenc...
Benzinga Newsdesk
Chardan Capital Maintains Buy on Silence Ther...
Benzinga Newsdesk

Thursday, June 27, 2024

HC Wainwright & Co. Reiterates Buy on Silence...
Benzinga Newsdesk
Silence Therapeutics Reports Results From Ong...
Benzinga Newsdesk

Monday, June 24, 2024

Silence Therapeutics To Receive $2M Research ...
Benzinga Newsdesk

Thursday, June 20, 2024

The Analyst Landscape: 6 Takes On Silence Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Silence...
Benzinga Newsdesk
Silence Therapeutics Announces Topline 48-Wee...
Benzinga Newsdesk

Friday, May 31, 2024

HC Wainwright & Co. Reiterates Buy on Silence...
Benzinga Newsdesk

Friday, May 24, 2024

HC Wainwright & Co. Reiterates Buy on Silence...
Benzinga Newsdesk

Friday, May 17, 2024

HC Wainwright & Co. Reiterates Buy on Silence...
Benzinga Newsdesk
What 7 Analyst Ratings Have To Say About Silence Therapeutics
Benzinga Insights
Chardan Capital Maintains Buy on Silence Ther...
Benzinga Newsdesk

Thursday, May 16, 2024

Silence Therapeutics Q1 Collaboration Revenue...
Benzinga Newsdesk

Monday, April 22, 2024

Beyond The Numbers: 7 Analysts Discuss Silence Therapeutics Stock
Benzinga Insights
Morgan Stanley Maintains Overweight on Silenc...
Benzinga Newsdesk

Monday, April 08, 2024

Silence Therapeutics Announces JAMA Publicati...
Benzinga Newsdesk

Friday, March 15, 2024

HC Wainwright & Co. Reiterates Buy on Silence...
Benzinga Newsdesk

Thursday, March 14, 2024

These Analysts Boost Their Forecasts On Silence Therapeutics After Full Year 2023 Results
Avi Kapoor
Morgan Stanley Maintains Overweight on Silenc...
Benzinga Newsdesk
Chardan Capital Maintains Buy on Silence Ther...
Benzinga Newsdesk

Wednesday, March 13, 2024

What 4 Analyst Ratings Have To Say About Silence Therapeutics
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Silence ...
Benzinga Newsdesk
What's Going On With Silence Therapeutics Stock Today?
Nabaparna Bhattacharya
Silence Therapeutics Reported 2023 Revenue of...
Benzinga Newsdesk
Silence Therapeutics Announces Topline 36-Wee...
Benzinga Newsdesk
Earnings Scheduled For March 13, 2024
Benzinga Insights

Tuesday, March 12, 2024

Earnings Scheduled For March 12, 2024
Benzinga Insights

Friday, February 23, 2024

Silence Therapeutics Achieves $10M Milestone ...
Benzinga Newsdesk

Thursday, February 22, 2024

HC Wainwright & Co. Reiterates Buy on Silence...
Benzinga Newsdesk

Monday, February 05, 2024

Silence Therapeutics Announces Oversubscribed...
Benzinga Newsdesk

Wednesday, January 31, 2024

Boeing Posts Upbeat Results, Joins Stryker, Automatic Data Processing And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Silence Therapeutics shares are trading highe...
Benzinga Newsdesk
BMO Capital Initiates Coverage On Silence The...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved